Literature DB >> 7471850

Self-induced pulmonary granulomatosis. A consequence of intravenous injection of drugs intended for oral use.

B F Waller, W J Brownlee, W C Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7471850     DOI： 10.1378/chest.78.1.90

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  9 in total

Review 1.  Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

2.  Dyspnea and bilateral interstitial pulmonary infiltrates in an intravenous drug user.

Authors:  Bradley S Jones; Frank A Brancaccio; Gabriel A Rodriguez
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

3.  Talc induced pulmonary granulomatosis.

Authors:  S E Low; S U Low; A Nicol
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

Review 4.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

5.  Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers.

Authors:  M R Lofwall; D E Moody; W B Fang; P A Nuzzo; S L Walsh
Journal:  J Clin Pharmacol       Date:  2011-05-24       Impact factor: 3.126

6.  Pulmonary "mainline" granulomatosis: talcosis secondary to intravenous heroin abuse with characteristic x-ray findings of asbestosis.

Authors:  L L Davis
Journal:  J Natl Med Assoc       Date:  1983-12       Impact factor: 1.798

7.  Cellulose granuloma in the lungs of a cocaine sniffer.

Authors:  C B Cooper; T R Bai; E Heyderman; B Corrin
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-25

Review 8.  A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.

Authors:  Michelle R Lofwall; Sharon L Walsh
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

9.  Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France.

Authors:  Perrine Roux; Daniela Rojas Castro; Khadim Ndiaye; Laélia Briand Madrid; Virginie Laporte; Marion Mora; Gwenaelle Maradan; Stéphane Morel; Bruno Spire; Patrizia Carrieri
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.